Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Orexo
Pharma
Orexo seeks approval of nasal high-dose opioid rescue medicine
Orexo is on track to bring a nasal naloxone formulation based on its amorphOX drug delivery technology to market in the first half of 2024.
Nick Paul Taylor
Feb 7, 2023 8:40am
Orexo unveils nasal EpiPen rival, sets sights on 2022 trial
Dec 7, 2021 10:05am
Orexo backs up new digital therapeutic launches with social
Oct 15, 2020 8:10am